Athersys Inc (NASDAQ:ATHX)
| 0.8134 Delayed Data As of Jan 24 |  +0.0172 / +2.16%Today’s Change | 0.75 Today|||52-Week Range 3.03 | -9.88% Year-to-Date |
Latest ATHX News | Press Releases
No recent news for Athersys Inc.
Today’s Trading
| Previous close | 0.80 |
| Today’s open | 0.80 |
| Day’s range | 0.75 - 0.83 |
| Volume | 62,780 |
| Average volume (3 months) | 1,631,725 |
| Market cap | $189.8M |
Data as of 4:03pm ET, 01/24/2022
Growth & Valuation
| Earnings growth (last year) | -42.94% |
| Earnings growth (this year) | +11.31% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -74.44% |
| P/E ratio | NM |
| Price/Sales | 227.83 |
| Price/Book | 5.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LPTXLeap Therapeutics In... | -0.09 | -4.50% |
| ALDXAldeyra Therapeutics... | +0.20 | +6.15% |
| NMTR9 Meters Biopharma I... | +0.01 | +1.59% |
| FIXXHomology Medicines I... | +0.10 | +2.97% |
Data as of 4:03pm ET, 01/24/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$78.8M |
| Net profit margin | -5,469.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cleveland, Ohio |
Forecasts
